Show Menu
Cheatography

ER Drugs- Nursing Pharmacology Cheat Sheet by

Emergency Room Top 15 Drugs

Epinep­hrine Trade: Adrenalin

Category Class
Pharm: adrenergic Ther: anti asthmatic, bronch­odi­lator, vasopr­essor
Action
Affects both beta1 (cardiac) & beta2 (pulmo­nary) receptor sites. Produces bronch­odi­lator. Also has alpha adrenergic agonist properties which result in vasoco­nst­ric­tion.
Indica­tions
Severe allergic reactions, hypote­nsion assoc. w/ septic shock, adjunct in locali­zat­ion­/pr­olo­ngation of anesth­esia, Cardiac arrest (VF, pulseless VT, systole, PEA), asthma
Adverse effects
restle­ssness, tremor, angina, arrhyt­hmia, hypert­ension, tachyc­ardia, necrot­izing fasciitis, PARADO­XICAL BRONCH­OSPASM (EXCESSIVE USE OF INHALERS)
Contra­ind­ica­tio­ns/­Pre­cau­tions
CI: hypers­ens­iti­vity; Caution: CV disease, HTN, hypert­hyr­oidism, DM, cerebral arteri­osc­ler­osis, glaucoma, Parkin­son's, OB/lac­tation, geriatric (more suscep­tible to adverse reactions; may require decrease dose)
Intera­ctions
Additive adrenergic side effects w/ other adrenergic drugs; Decreased therap­eutic effects w/ adrenergic antago­nists (some antiHTNs); Anesth­etics can increase risk for dysrhy­thmias; MAOIs may cause life-t­hre­atening hypert­ensive crisis; Antihi­stamine & thyroid preps can ^ effects of adrene­rgics
Dosage
Anaphy­laxis: SubQ 0.3-0.5 mg repeated q10-15 min if required; Cardiac arrest: IV 1 mg q3-5 min if required
Nursing Interv­entions
Obtain past & present medication hx; Accurate dosing, use, pump settings ABG levels & ECG findings; Liver & renal function tests; Monitor IV infusion site; Assess RR, pulse, & BP before, during and after admin;

Adenosine Trade: Adenocard

Category Class
Action
Indica­tions
Contra­ind­ica­tions
Adverse Effects
Intera­ctions
Dosage
Nursing Interv­entions

Amiodarone Trade: Paceron

Category Class
Class III antiar­rhy­thmics
Action
Prolongs action potential duration and effective refractory period, noncom­pet­itive α- and β-adre­nergic inhibi­tion; increases PR and QT intervals, decreases sinus rate, decreases peripheral vascular resistance
Indica­tions
Hemody­nam­ically unstable Vtach, SVT, Vfib not controlled by 1st-line agents
Adverse Effects
visual distur­bances, photos­ens­iti­vity, BBW: hepato­tox­icity, pulmonary toxicity, proarh­ythmic effects
Contra­ind­ica­tions/ Precau­tions
CI: Pregna­ncy/BF, infants, severe sinus node dysfun­ction, hypers­ens­itivity to this produc­t/i­odi­ne/­benzyl alcohol, cardio­genic shock BLACK BOX WARNING: 2nd-3rd degree AV block, bradyc­ardia; Precau­tions: Goiter, Hashim­oto’s thyroi­ditis, electr­olyte imbala­nces, HF, severe respir­atory disease, children, torsades de pointes BLACK BOX WARNING: Cardiac arrhyt­hmias, pneumo­nitis, pulmonary fibrosis, severe hepatic disease
Intera­ctions
digoxin: increased blood levels, increased toxicity; Warfarin: increased bleeding, dabigatran
Dosage
IV: 150 mg over 10 min; PO: usual mainte­nance 200-600 mg/day
Nursing Interv­entions
monitor PT, INR if using warfarin; Monitor ECG, BP contin­uously; Monitor for adverse effects

Atropine

Category Class
Pharm: antich­oli­nergic Ther: antiar­rhy­thmics
Action
Blocks acetyl­choline at parasy­mpa­thetic neuroe­ffector sites; increases cardiac output, heart rate by blocking vagal stimul­ation in heart; dries secretions by blocking vagus
Indica­tions
Bradyc­ardia, bradyd­ysr­hyt­hmia, reversal of antich­oli­nes­terase agents, decreasing secretions before surgery, antisp­asmodic with GU and biliary surgery, bronch­odi­lator, AV heart block, rapid-­seq­uence intubation
Adverse Effects
tachyc­ardia, dysrhy­thmias, consti­pation, sedation, urinary retention
Contra­ind­ica­tions/ Precau­tions
angle-­closure glaucoma; caution: severe renal/­hepatic dysfun­ction, hiatal hernia assoc. w/ reflux esopha­gitis, intestinal atony, GI/GU obstru­ction, severe ulcerative colitis
Intera­ctions
additive anti-c­hol­inergic effects w/ other drugs that possess same side effects (amant­adine, antihi­sta­mines, tricyclic antide­pre­ssa­nts); increased effects of digoxin when combined
Dosage
IV 0.5- 1 mg q3-5 min (max 3 mg)
Nursing Interv­entions
Monitor I&O ratio; Monitor ECG; Monitor for bowel sounds; Monitor respir­atory status & cardiac status; Beers: Avoid in older adults

Dopamine

Category Class
Ther: ­Ago­nist, vasopr­essor, inotropic agent Pharm:­ Ca­tec­hol­amine
Action
Causes increased cardiac output; acts on β1- and α-rece­ptors, causing vasoco­nst­riction in blood vessels; when low doses are admini­stered, causes renal and mesenteric vasodi­lat­ation; β1 stimul­ation produces inotropic effects with increased cardiac output
Indica­tions
Shock; to increase perfusion; hypote­nsion, cardio­gen­ic/­septic shock
Contra­ind­ica­tio­ns/­Pre­cau­tions
CI: Hypers­ens­iti­vity, Vfib, tachyd­ysr­hyt­hmias, pheoch­rom­ocy­toma, hypovo­lemia; Precau­tions: OB/Lac­tation, geriatric, arterial embolism, PVD, sulfite hypers­ens­iti­vity, acute MI; BLACK BOX WARNING: Extrav­asation
Adverse Effects
Palpit­ations, tachyc­ardia, HTN, ectopic beats, angina, wide QRS complex, Necrosis, tissue sloughing w/extr­ava­sation, gangrene, headache, diarrhea
Intera­ctions
α-Adre­nergic & β-adre­nergic blockers: decreased action of Dopamine; Anesth­etics (general): increased dysrhy­thmias; Antide­pre­ssants (tricy­clic): increased pressor response; MAOIs: increased HTN (severe), do not use within 2 wk; Oxytocics: increased BP; Phenytoin: bradyc­ardia, hypote­nsion
Dosage
IV 1-50 mcg/kg/min
Nursing Interv­entions
• Monitor ECG for dysrhy­thmias; also monitor PCWP, CVP, CO2, urinary output; Assess for HF; Assess for oxygen­ation or perfusion deficit; Monitor BP & HR q5min during inf; if BP drops 30 mmHg, stop inf & call prescr­iber; BBW: Check for extrav­asa­tion: if this occurs, admin phento­lamine mixed w/0.9% NaCl

Magnesium Sulfate HIGH ALERT

Category Class
Func. class:­ ​E­lec­tro­lyte; antico­nvu­lsant, laxative, saline; antacid
Action
Increases osmotic pressure, draws fluid into colon, neutra­lizes HCl
Indica­tions
Consti­pation, bowel prep, antico­nvu­lsant, preterm labor, preecl­amp­sia­/ec­lam­psia; tx of torsades, adjunct tx for bronch­odi­lation in modera­te-­severe acute asthma
Contra­ind­ica­tio­ns/­Pre­cau­tions
CI: Hypers­ens­iti­vity, abdominal pain, N/V, obstru­ction, acute surgical abdomen, rectal bleeding, heart block, myocardial damage; Precau­tions: Pregnancy, renal diseas­e/c­ardiac disease
Adverse Effects
respir­atory depres­sio­n/p­ara­lysis, bradyc­ardia, hypote­nsion, hypoth­ermia, arrhyt­hmias, diarrhea, prolonged bleeding times, cramps
Intera­ctions
Antihy­per­ten­sives (CCB): increased hypote­nsion; Antiin­fec­tives (fluor­oqu­ino­lones, tetrac­ycl­ines): decreased absorp­tion; Neurom­uscular blockers: increased effects; Digoxin: decreased effect of digoxin; Nitrof­ura­ntoin: decreased absorption
Dosage
Seizur­es/HTN: IM/IV 1 g q6h for 4 doses prn; Torsades: IV (infants &c­hil­dren) 25-50 mg/kg/dose q4-6h prn; Bronch­odi­lation: IV (adults) 2 g single dose, (children) IV 25 mg/kg/­dose; Eclamp­sia­/Pr­eec­lam­psia: IV/IM 4-5 g infusion, concur­rently w/up to 5 g in each buttock, then 4-5 g IM q4h or IV inf 4 g followed by 1-2 g/h continuous infusion
Nursing Interv­entions
Monitor HR, BP, RR, & ECG freq throughout IV admin; Monitor neuro status, initiate seizure precau­tions; Assess patellar reflex before each IV dose: if absent, do not admin; Monitor I&O ratios; Monitor newborn for hypote­nsion, hypore­flexia, & respir­atory depres­sion; Monitor serum mag levels & renal functions period­ically

Sodium Bicarb­onate

Category Class
Pharm: alkali­nizing agent; Ther: anti ulcer agent
Action
acts as an alkali­nizing agent by releasing bicarb­onate ions; oral admin, releases bicarb­onate which neutra­lizes gastric acid
Indica­tions
management of metabolic acidosis, alkalinize urine & promote excretion of certain drugs in OD; antacid; stabil­ization of acid-base status in cardiac arrest; tx of life-t­hre­atening hyperk­alemia
Contra­ind­ica­tio­ns/­Pre­cau­tions
CI: Respir­ato­ry/­met­abolic alkalosis, hypoch­lor­emia, hypoca­lcemia; Precau­tions: Pregnancy, HF, cirrhosis, toxemia, renal disease, HTN, hypoka­lemia, lactation, hypern­atr­emia, Cushing’s syndrome, children
Adverse Effects
metabolic alkalosis, edema, tetany, gastric distention
Intera­ctions
Amphet­amines, anorex­iants, sympat­hom­ime­tics: increased blood levels; decreased effects of ketoco­nazole; urinary alkali­zation may decrease salicylate or barbit­urate blood levels; increase risk of crysta­lluria from quinol­ones; may negate protective effects of enteri­c-c­oated products (do not admin w/in 1-2 hr)
Dosage
Systemic Alkali­zat­ion­/Ca­rdiac Arrest: urgent- IV 1 mEq/ kg, may repeat 0.5 mEq/kg q10 min; less urgent- 2-5 mEq/kg as 4-8h infusion; Alkali­zation of Urine: PO (Adults) 48 mEq (4g) initially, then 12-24 mEq q4h, IV 2-5 mEq/kg as 4-8h infusion; Antacid tabs 325 mg- 2 g 1-4x/day
Nursing Interv­entions
Assess fluid balance, fluid overload, for s/s of acidosis, alkalosis, hypern­atr­emia, or hypoka­lemia; observe IV site closely for extrav­asa­tion; Assess for epigastric pain, bloody stools­/em­esi­s/g­astric aspirate; monitor ABGS, urine pH, renal function, gastric acid secretion test, electr­olyte levels, serum osmola­rity; advise pt to avoid milk products (milk-­alkali syndrome)
 

Etomidate HIGH ALERT

Category Class
Pharm: nonbar­bit­urates; Ther: general anesth­etics
Action
Hypnotic CNS depressant w/out analgesic activity
Indica­tions
induction of general anesth­esia; supple­mental anesthesia w/other agents (nitrous oxide) for short procedures
Contra­ind­ica­tio­ns/­Pre­cau­tions
CI: Hypers­ens­iti­vity, prolonged infusion not recomm­ended (surpasses cortisol produc­tion), Pregnancy, L&D; Precau­tions: severe stress (may require supple­mental cortic­ost­ero­ids), geriatric, lactation, children < 10yr
Adverse Effects
apnea, laryng­ospasm, transient skeletal muscle movements, hypo/h­ype­rte­nsion, arrhyt­hmias, hypo/h­ype­rve­nti­lation
Intera­ctions
Increase CNS depression w/other CNS depres­sants including antihi­sta­mine, antide­pre­ssants, sedati­ve/­hyp­notics, antips­ych­otics, and opioids (decrease dose of others); verapamil may increase anesthetic effect, which may increase risk of respir­atory depression & apnea
Dosage
IV 0.2-0.6 mg/kg (usual 0.3 mg/kg) for induction
Nursing Interv­entions
Assess respir­atory status, HR, & BP contin­uously; Maintain patent airway & adequate ventil­ation; Assess level of sedation & LOC throughout & following admin; May cause inj site pain; Monitor for toxicity OD; HIGH ALERT: should only used by indivi­duals experi­enced with endotr­acheal intuba­tion; have airway equip readily available

Succin­ylc­holine Trade: Anectine, Quelicin

Category Class
Func. class:­ ​N­eur­omu­scular blocker (depol­ari­zin­g—ultra short)
Action
Inhibits transm­ission of nerve impulses by binding with cholin­ergic receptor sites, antago­nizing action of acetyl­cho­line; causes release of histamine
Indica­tions
Facili­tation of endotr­acheal intuba­tion, skeletal muscle relaxation during orthopedic manipu­lations
Contra­ind­ica­tio­ns/­Pre­cau­tions
CI: Hypers­ens­itivity to succin­ylc­holine or parabens, malignant hypert­hermia; Precau­tions: Pregnancy, lactation, geriatric or debili­tated patients, severe burns, fractures, electr­olyte imbala­nces, neurom­uscular disease, glaucoma, renal/­hep­ati­c/c­ard­iac­/re­spi­ratory disease, hyperk­alemia; BBW: Myopathy, rhabdo­myo­lysis, children <2 yr
Adverse Effects
Apnea, hyperk­alemia, rhabdo­myo­lysis, anaphy­laxis, malignant hypert­hermia, arrhyt­hmias, bradyc­ardia, hypote­nsion, bronch­ospasm
Intera­ctions
Intensity &/or duration of paralysis may be prolonged by pretre­atment w/ general anesth­etics, aminog­lyc­osides, polymy­xinB, colistin, clinda­mycin, lidocaine, quinidine, procai­namide, beta blockers, lithium, cyclop­hos­pha­mide, phenel­zine, potass­ium­-losing diuretics, & magnesium salts; Increase risk of adverse CV reactions w/ opioid analgesics or digoxin
Dosage
Short proced­ures: IV 0.6 mg/kg up to 150 mg total dose, mainte­nance 0.3-0.6 mg/kg q5-10 min prn; Prolonged proced­ures: IV 2.5 mg/min infusion; IM dose up to 3-4 mg/kg (do not exceed 150 mg)
Nursing Interv­entions
Assess respir­atory status contin­uously; Monitor neurom­uscular response; Monitor ECG, HR, & BP; Assess for hx of malignant hypert­hermia before admin and monitor for signs throug­hout; Have airway equip readily available; monitor for hyperk­alemia; HIGH ALERT: admin w/out ventil­atory support results in serious harm and death, use caution and verify correct med and dosage

Propofol Trade: Diprivan

Category Class
Ther: general anesth­etics Func: hypnotic
Action
Produces dose-d­epe­ndent CNS depression by activation of GABA receptor; short-­acting hypnotic; produces amnesia
Indica­tions
Induction or mainte­nance of anesthesia as part of balanced anesthetic technique; sedation in mechan­ically ventilated patients
Contra­ind­ica­tio­ns/­Pre­cau­tions
Hypers­ens­itivity to product or soybean oil, egg, benzyl alcohol, OB/Lac­tation; Precau­tions: CV disease, lipid disorders, increased ICP, cerebr­ova­scular disorder, hypovo­lemia, pediat­rics, geriatrics
Adverse Effects
apnea, bradyc­ardia, hypo (more common­)/h­ype­rte­nsion, green urine, burning pain or stinging at IV site, PROPOFOL INFUSION SYNDROME
Intera­ctions
Additive CNS & respir­atory depression w/ alcohol, antihi­sta­mine, opioid analge­sics, & sedati­ve/­hyp­notics; Theoph­ylline may antagonize CNS effect of propofol; Cardio­res­pir­atory instab­ility w/ acetaz­ola­mide; serious bradyc­ardia w/ fentanyl use in children; increase risk hypert­rig­lyc­eri­demia w/ intrav­enous fat emulsion
Dosage
ICU sedation Adult: ​IV 5 mcg/kg/min over 5 min; may increase by 5-10 mcg/kg/min over 5-10 min until desired response
Nursing Interv­entions
Assess respir­atory status, pulse, & BP contin­uously; airway mainte­nance equip readily available; assess level of sedation & LOC throughout & following admin; ICU sedation: wake-up & assess CNS function daily, abrupt d/c may cause rapid awakening w/ anxiety and mechanical ventil­ation resist­ance; assess for propofol infusion syndrome

Naloxone Trade: Narcan

Category Class
Ther: antidote; Pharm: opioid antagonist
Action
Compet­ively blocks effects of opioids, including CNS & respir­atory depres­sion, without producing any agonist (opioi­d-like) effects
Indica­tions
Reversal of CNS & respir­atory depression because of suspected opioid OD
Contra­ind­ica­tio­ns/­Pre­cau­tions
CI: Hypers­ens­itivity ; Precau­tions: CV disease, pt physically dependent on opioids, OB/lac­tation, pediatrics
Adverse Effects
Ventri­cular arrhyt­hmias, hypo/h­ype­rte­nsion, N/V
Intera­ctions
Can precip­itate withdrawal in pts physically dependent on opioids; larger doses may be required to reverse effects of bupren­orp­hine, butorp­hanol, or nalbup­hine; antago­nizes post-op opioid analgesics
Dosage
Opioid OD tx: IV 0.4-2 mg, repeat 2-8 min prn; Post-op anesthesia reversal: IV 0.1-0.2 mg, repeat at 2-3 min intervals
Nur
Monitor respir­atory status, pulse, ECG, BP, & LOC frequently for 3-4h after the expected peak of blood concen­tra­tions; pt receiving opioids >1wk have increased sensit­ivity to effects, dilute & admin in slow increm­ents; Assess pain level in post-op respir­atory depres­sion; Assess s/s of withdrawal

Diltiazem Trade: Cardizem

Category Class
Pharm: CCB; Ther: antian­ginal, Class IV antiar­rhy­thmics, antihy­per­tensive
Action
Inhibits transport of calcium into myocardial & vascular smooth muscle cells resulting in inhibition of excita­tio­n-c­ont­raction coupling and subsequent contra­ction; produces relaxation of coronary vascular smooth muscle, dilates coronary arteries, slows SA/AV node conduction times, dilates peripheral arteries
Indica­tions
HTN; angina pectoris & vasosp­astic (Prinz­men­tal's) angina; Suprav­ent­ricular tachya­rrh­ythmias and rapid ventri­cular rates in atrial flutter or fibril­lation
Contra­ind­ica­tio­ns/­Pre­cau­tions
CI: Sick sinus syndrome, 2nd- or 3rd-degree heart block, Systolic BP < 90, recent MI or pulmonary conges­tion; Precau­tions: OB/Lac­tat­ion­/Pedi, HF, severe renal/­hepatic disease, ventri­cular dysfun­ction, geriatric
Adverse Effects
peripheral edema, arrhyt­hmias, HF, SJS, tachyc­ard­ia/­bra­dyc­ardia, hypote­nsion, dyspnea
Intera­ctions
Increase hypote­nsion may occur w/ fentanyl, other antihy­per­ten­sives, nitrates, alcohol ingestion, or quinidine; Antihy­per­tensive effects may decrease w/ NSAIDS; Beta Blockers may result in bradyc­ardia & AV block; Increase digoxin levels; Statins increase risk for statin toxicity; azole antifu­ngals, clarit­hro­mycin, erythr­omycin, HIV drugs may decrease metabolism resulting in elevated levels & effects of CCBs; cyclos­porine increase risk of toxicity to either drug
Dosage
PO initial dose 30 mg qid; range of 120-360 mg divided in 3-4 doses; ER: 120-320 mg/day; IV 0.25mg/kg, may repeat in 15 min w/dose of 0.35 mg/kg. May follow w/ continuous infusion at 10 mg/h (range 5-15 mg/h) for up to 24h.
Nursing Interv­entions
Monitor BP & pulse before, throug­hout, & after; Monitor ECG period­ically w/ prolonged therapy; Monitor I&O ratios & daily weights; Assess signs of HF; Assess for SJS; Assess location, duration, intensity, & precip­itating factors of angina; Report bradyc­ardia or prolonged hypote­nsion immedi­ately, emergency equip & medication readily available; Monitor serum potassium, renal/­hepatic functions period­ically

Aspirin

Category Class
Ther: antipy­retic, nonopioid analgesic; Pharm: salicy­lates
Action
Produce analgesia by Blocks pain impulses by blocking COX-1 in CNS; reduce inflam­mation by inhibiting prosta­glandin synthesis; antipy­retic action results from vasodi­lat­ation of peripheral vessels; decreases platelet aggreg­ation
Indica­tions
Inflam­matory disorders including rheumatoid arthritis & osteoa­rth­ritis; mild-m­oderate pain; fever; prophy­laxis of TIAs & MI
Contra­ind­ica­tio­ns/­Pre­cau­tions
CI: Hypers­ens­itivity to salicy­lates or NSAIDs, bleeding disorders or thromb­ocy­top­enia, pediat­rics; Precau­tions: hx of GI bleed or ulcer disease, chronic alcohol abuse, severe renal/­hepatic disease, OB/Lac­tation, geriatrics
Adverse Effects
GI Bleed, dyspepsia, epigastric distress, anaphy­laxis, laryngeal edema, tinnitus
Intera­ctions
Increase risk bleeding w/ heparin, warfarin, thromb­olytic agents; Ibuprofen may negate the cardio protective antipl­atelet effects; Combined use w/ steroids or non aspirin NSAIDS increases GI irritation
Dosage
MI prophy­laxis: PO 81-325 mg/day; Pain/F­ever: 325-1000 mg q4-6hr; Inflam­mation: PO 2.4 g/day initially, increase to mainte­nance dose of 3.6-5.4 g/day divided doses; TIA prophy­laxis: PO 50-325 mg/day
Nursing Interv­entions
Pt w/ asthma, allergies, nasal polyps, or allergic to tartrazine have increased risk hypers­ens­iti­vity; Assess pain type, location, intensity; Assess fever and signs; Monitor hepatic function, serum salicylate levels, hemato­crit, and bleeding times

Nitrog­ycerin

Category Class
Ther: ­​Co­ronary vasodi­lator, antian­ginal; Pharm:­ ​N­itrate
Action
Decreases preload and afterload; Increases coronary blood flow by dilating coronary arteries & improving collateral flow to ischemic regions; produces vasodi­lation (venous > arterial); reduced myocardial O2 consum­ption
Indica­tions
Chronic stable angina pectoris, prophy­laxis of angina pain, HF associated with acute MI, controlled hypote­nsion in surgical procedures
Contra­ind­ica­tio­ns/­Pre­cau­tions
CI: hypers­ens­iti­vity, increased ICP, cerebral hemorr­hage, closed­-angle glaucoma, cardiac tamponade, hypovo­lemia, constr­ictive perica­rditis, severe anemia; Precau­tions: head trauma, cerebral hemorr­hage, glaucoma, cardio­myo­pathy, severe liver impair­ment, malabs­orption or hyper motility, cardio­ver­sion, OB/Lac­tat­ion­/Pedi
Adverse Effects
dizziness, headache, hypote­nsion, tachyc­ardia
Intera­ctions
Alcohol: increased hypote­nsion, CV collapse; Aspirin: increased nitrate level; Heparin: decreased effects (with IV nitrog­lyc­erin); Avanafil, silden­afil, tadalafil, varden­afil: increased fatal hypote­nsion, do not use together; Antihy­per­ten­sives, β-adre­nergic blockers, CCBs, diuretics: increased hypote­nsion
Dosage
Adult: ​SL dissolve tab under tongue when pain begins; may repeat q5min until relief; do not exceed 3 tab/15 min; use 1 tab prophy­lac­tically 5-10 min before activi­ties; TOP 1-2 inches q8hr; increase to 4 in q4hr prn; IV 5 mcg/min, then increase 5 mcg/min q3-5min; if no response after 20 mcg/min, increase 10-20 mcg/min until desired response; transd­ermal apply patch daily; remove patch at bedtime to avoid tolerance
Nursing Interv­entions
Assess location, duration, intensity, & precip­itation factors of angina; Monitor BP & pulse before­/after; Continuous ECG & BP monitoring for IV use

Morphine HIGH ALERT

Category Class
Ther: opioid analgesic Pharm: opioid agonist
Action
Binds to opiate receptors in CNS, alters perception of & response to painful stimuli while producing genera­lized CNS depression
Indica­tions
Moderate to severe pain Unlabeled uses: Agitation, bone/d­ental pain, dyspnea in end-stage cancer or pulmonary disease, sedation induction, rapid-­seq­uence intubation
Contra­ind­ica­tio­ns/­Pre­cau­tions
CONTRA­IND­ICA­TIONS Hypers­ens­iti­vity, addiction (opioi­d/a­lco­hol), hemorr­hage, bronchial asthma, increased ICP, paralytic ileus; BBW: Respir­atory depres­sion; Precau­tions: OB/Lac­tation, children, geriatric, acute MI, severe cardio­/pu­lmo­nar­y/r­ena­l/h­epatic disease, abrupt d/c, seizures; BBW: Accidental exposure, epidur­al/­int­rat­hec­al/­IM/SubQ admini­str­ation, opioid­-naive patients, substance abuse
Adverse Effects
Respir­atory depres­sio­n/a­rrest, bradyc­ardia, hypote­nsion, tolerance, dependance
Intera­ctions
Alcohol: increased effects with other CNS depres­sants; Rifampin: decreased analgesic action; Antips­ych­otics, opiates, sedati­ve-­hyp­notics, skeletal muscle relaxants: increased effects with other CNS depres­sants; MAOIs: unpred­ictable reaction may occur; avoid use; Chamomile, kava, St. John’s wort, valerian: increased CNS depression
Dosage
PO regula­r-r­elease Adult ≥50 kg: ​I­nit­ially, 10-30 mg q3-4hr prn; Adult <50 kg/ger­iatric patient: May require lower doses and/or extended dosing intervals, doses should be titrated carefully; IV/IM/­subcut Adult ≥50 kg: ​2.5-15 mg q2-6hr as needed, titrate or a loading dose of 0.05-0.1 mg/kg IV, followed by 0.8-10 mg/hr IV, titrate Adult <50 kg/ger­iatric patien­t: ​May require lower doses and/or extended dosing intervals 0.1 mg/kg q3-4hr, titrate
Nursing Interv­entions
Assess pain: location, type, character, intensity, give dose before pain becomes extreme; Monitor I&O, CNS changes; BBW: Abrupt discon­tin­uation: gradually taper to prevent withdrawal symptoms, Accidental exposure: if Duramorph or Infamorph gets on skin, remove contam­inated clothing and rinse affected area with water;­Assess respir­atory dysfun­ction: depres­sion, character, rate, rhythm; notify prescriber if respir­ations are <12/min
   
 

Comments

No comments yet. Add yours below!

Add a Comment

Your Comment

Please enter your name.

    Please enter your email address

      Please enter your Comment.

          Related Cheat Sheets

          FREQUENTLY USED DX CODES Cheat Sheet
          Fibromyalgia Medications Cheat Sheet
          Drug Classes & Actions : NSAIDs Cheat Sheet